Fondaparinux in patients with ST-segment elevation myocardial infarction.
Peeters
Michael J
MJ
Sydoruk
Borys
B
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005170:Factor X / Q000037:antagonists & inhibitors*; D000077425:Fondaparinux; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010314:Partial Thromboplastin Time; D011134:Polysaccharides / Q000009:adverse effects / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000453:epidemiology; D012306:Risk; D020246:Venous Thrombosis / Q000453:epidemiology
D000925:Anticoagulants; D011134:Polysaccharides; D005170:Factor X; D000077425:Fondaparinux